Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists

István Borza, Sándor Kolok, Györgyi Ignácz-Szendrei, István Greiner, Gábor Tárkányi, Kornél Galgóczy, Csilla Horváth, Sándor Farkas, György Domány

Research output: Contribution to journalArticle

15 Citations (Scopus)


A novel series of indole-2-carboxamidine derivatives was prepared and identified as NR2B selective NMDA receptor antagonists. The influence of the substituents on the indole skeleton as well as the substitution of the benzyl moiety on the biological activity of the compounds was studied. Compound 5a was po active in the formalin test in mouse.

Original languageEnglish
Pages (from-to)5439-5441
Number of pages3
JournalBioorganic and Medicinal Chemistry Letters
Issue number24
Publication statusPublished - Dec 15 2005



  • Indole-2-carboxamidine
  • NB2B
  • NMDA

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Borza, I., Kolok, S., Ignácz-Szendrei, G., Greiner, I., Tárkányi, G., Galgóczy, K., Horváth, C., Farkas, S., & Domány, G. (2005). Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists. Bioorganic and Medicinal Chemistry Letters, 15(24), 5439-5441.